Clearside BioMedical director resigns
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall
Global M&A By the Numbers: Q1 2022
Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes
Clearside BioMedical Inc. said July 5 that Gerald Cagle stepped down from its board of directors.
Alpharetta, Ga.-based Clearside BioMedical develops pharmacological therapies for blinding eye diseases.